減量薬の世界市場レポート 2024年

減量薬の市場規模は、今後数年間で急激に成長すると予想されています。 2028年には43.5%の年間複合成長率（CAGR）で121億7,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、高齢者人口の増加、ソーシャルメディアの影響、フィットネスとウェルネスの動向、美に対する文化的認識、製薬業界による継続的な投資などの要因に起因すると考えられます。予測期間中に予想される主要動向には、技術の進歩、処方箋なしのソリューションへの注目、個別化医療の出現、併用療法の探求、進行中の製品革新、市販後調査の重視などが含まれます。これらの動向は、多様なニーズや好みを満たす戦略やソリューションの進化に焦点を当てた、減量薬業界のダイナミックな情勢を示唆しています。

予想される肥満率の増加は、減量薬市場の成長を促進すると予想されます。肥満率は、人口における体格指数（BMI）が30以上の個人の割合として定義されます。減量薬は、食欲の低下、満腹感の増加、または栄養素の吸収の妨げ。 2023年9月、疾病管理予防センターは、成人肥満率が2021年には19州、2022年には22州で35%を超え、2022年には有病率が35%以上になると報告しました。さらに、世界肥満連盟は、成人肥満率が4%以上であると推定しました。 2035年までに10億人が肥満になると予想されています。肥満率の上昇は、減量薬市場の成長の主要原動力です。

減量薬市場の大手企業は、患者により良いサービスを提供する革新的な製品の開発に注力しています。そのような例の1つは、週 1回注射なグルコース依存性インスリン分泌性ポリペプチド（GIP）とグルカゴンなどのペプチド 1（GLP-1）受容体の二重アゴニストであるZepbound（チルゼパチド）注射です。 2023年11月、米国に本拠を置く製薬会社Eli Lilly and Companyは、過体重または肥満と少なくとも1つの体重関連疾患を持つ成人の慢性的な体重管理を目的としたチルゼパチド注射剤（Zepbound）のFDA承認を取得しました。 Zepboundは、GIP受容体とGLP-1受容体の両方を活性化する最初で唯一のFDA承認の肥満治療薬として際立っており、商業的成功の可能性を示しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の減量薬市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の減量薬の市場規模実績と成長、2018～2023年
• 世界の減量薬市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の減量薬市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 液体
• タブレット
• カプセル
• 世界の減量薬市場、流通チャネル別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の減量薬市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 減量補助具
• 脂肪吸収阻害剤
• 代謝促進剤

第7章 地域と国の分析

• 世界の減量薬市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の減量薬市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 減量薬市場の競合情勢
• 減量薬市場の企業プロファイル
  • Pfizer Inc.
  • Roche
  • Merck &Co.
  • AbbVie Inc.
  • Novartis AG

第31章 その他の主要と革新的な企業

• Bristol Myers Squibb
• Sanofi SA
• AstraZeneca plc
• LG Chem
• GlaxoSmithKline
• Takeda Pharmaceutical Company
• Eli Lilly and Company
• Bayer AG
• Amgen Inc.
• Boehringer Ingelheim group
• Novo Nordisk A/S
• Merck KGaA
• Teva Pharmaceutical Industries Ltd.
• Hisun Pharmaceutical
• Taj Pharmaceuticals Ltd

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

Weight loss drugs refer to pharmaceutical substances designed to reduce appetite and food cravings, ultimately leading to a decrease in calorie intake and subsequent weight loss. These drugs undergo approval from the U.S. Food and Drug Administration (FDA) and are prescribed by healthcare professionals to treat individuals suffering from obesity or those who are overweight and have accompanying weight-related medical conditions such as high blood pressure, type 2 diabetes, or high cholesterol.

Weight loss drugs come in various forms, with the main types being liquid, tablets, and capsules. Weight loss liquids refer to formulations designed to assist in weight management and the reduction of body weight. These liquids are available through different distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies. They may serve various purposes, such as aiding in weight reduction, acting as fat absorption inhibitors, or boosting metabolism.

The weight loss drugs market size has grown exponentially in recent years. It will grow from $1.94 billion in 2023 to $2.87 billion in 2024 at a compound annual growth rate (CAGR) of 47.8%. The growth observed in the historical period can be attributed to several factors, including the increasing rates of obesity, changes in lifestyle, heightened awareness and education about weight-related issues, early diagnosis of medical conditions, and a general rise in healthcare expenditure. These factors collectively contributed to a greater demand for weight loss drugs as individuals sought solutions to address and manage weight-related concerns during the historical period.

The weight loss drugs market size is expected to see exponential growth in the next few years. It will grow to $12.17 billion in 2028 at a compound annual growth rate (CAGR) of 43.5%. The anticipated growth in the forecast period can be attributed to factors such as the increasing geriatric population, the influence of social media, trends in fitness and wellness, cultural perceptions of beauty, and continued investments by the pharmaceutical industry. Key trends expected in the forecast period include advancements in technology, a focus on non-prescription solutions, the emergence of personalized medicine, the exploration of combination therapies, ongoing product innovation, and an emphasis on post-market surveillance. These trends suggest a dynamic landscape in the weight loss drug industry, with a focus on evolving strategies and solutions to meet diverse needs and preferences.

The anticipated increase in obesity rates is expected to drive the growth of the weight loss drugs market. Obesity rates are defined as the proportion of individuals in a population with a body mass index (BMI) equal to or greater than 30. Weight loss drugs play a crucial role in addressing obesity by assisting individuals in achieving weight loss through various mechanisms such as appetite reduction, increased feelings of fullness, or interference with nutrient absorption. In September 2023, the Centers for Disease Control and Prevention reported that adult obesity rates exceeded 35% in 19 states in 2021 and 22 states in 2022, with prevalence at or above 35% in 2022. Additionally, the World Obesity Federation estimated that over 4 billion people are expected to be obese by 2035. The rising obesity rates are a key driver for the growth of the weight loss drugs market.

Major companies in the weight loss drug market are focusing on the development of innovative products to better serve patients. One such example is Zepbound (tirzepatide) injection, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-such as peptide-1 (GLP-1) receptor agonist. In November 2023, Eli Lilly and Company, a US-based pharmaceutical company, received FDA approval for tirzepatide injection (Zepbound) for chronic weight management in adults with overweight or obesity and at least one weight-related condition. Zepbound stands out as the first and only FDA-approved obesity treatment that activates both GIP and GLP-1 receptors, showing potential for commercial success.

In December 2023, Roche Holding AG, a Switzerland-based healthcare company, successfully acquired Carmot Therapeutics Inc. for $2.7 billion. This strategic acquisition granted Roche access to two obesity drug candidates, including an injectable ready for phase 2 clinical trials and a daily pill version in phase 1 trials. The acquisition aimed to strengthen Roche's position in the competitive and growing obesity drug market. Carmot Therapeutics Inc., a US-based clinical-stage biotechnology company, specializes in the discovery and development of disease-modifying therapies for obesity and diabetes.

Major companies operating in the weight loss drugs market report are Pfizer Inc., Roche, Merck & Co., AbbVie Inc., Novartis AG, Bristol Myers Squibb, Sanofi S.A., AstraZeneca plc, LG Chem, GlaxoSmithKline, Takeda Pharmaceutical Company, Eli Lilly and Company, Bayer AG, Amgen Inc., Boehringer Ingelheim group, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Hisun Pharmaceutical, Taj Pharmaceuticals Ltd, Zhongshan Pharmaceutical Co. Ltd., Dm Pharma, Lunan Pharmaceutical Group Corporation, Wolfson Berg Ltd., Swiss Research Labs Ltd.

North America was the largest region in the Weight Loss Drugs market in 2023. The regions covered in the weight loss drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the weight loss drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The weight loss drugs market consists of sales of appetite suppressants, fat absorption inhibitors, and metabolism boosters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Weight Loss Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on weight loss drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for weight loss drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The weight loss drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Liquid; Tablets; Capsules
• 2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• 3) By Application: Weight-Reducing Aid; Fat Absorption Inhibitors; Metabolic Boosters
• Companies Mentioned: Pfizer Inc.; Roche; Merck & Co.; AbbVie Inc.; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Weight Loss Drugs Market Characteristics

3. Weight Loss Drugs Market Trends And Strategies

4. Weight Loss Drugs Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Weight Loss Drugs Market Size and Growth

• 5.1. Global Weight Loss Drugs Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Weight Loss Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Weight Loss Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Weight Loss Drugs Market Segmentation

• 6.1. Global Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Liquid
• Tablets
• Capsules
• 6.2. Global Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.3. Global Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Weight-Reducing Aid
• Fat Absorption Inhibitors
• Metabolic Boosters

7. Weight Loss Drugs Market Regional And Country Analysis

• 7.1. Global Weight Loss Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Weight Loss Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Weight Loss Drugs Market

• 8.1. Asia-Pacific Weight Loss Drugs Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Weight Loss Drugs Market

• 9.1. China Weight Loss Drugs Market Overview
• 9.2. China Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Weight Loss Drugs Market

• 10.1. India Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Weight Loss Drugs Market

• 11.1. Japan Weight Loss Drugs Market Overview
• 11.2. Japan Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Weight Loss Drugs Market

• 12.1. Australia Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Weight Loss Drugs Market

• 13.1. Indonesia Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Weight Loss Drugs Market

• 14.1. South Korea Weight Loss Drugs Market Overview
• 14.2. South Korea Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Weight Loss Drugs Market

• 15.1. Western Europe Weight Loss Drugs Market Overview
• 15.2. Western Europe Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Weight Loss Drugs Market

• 16.1. UK Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Weight Loss Drugs Market

• 17.1. Germany Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Weight Loss Drugs Market

• 18.1. France Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Weight Loss Drugs Market

• 19.1. Italy Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Weight Loss Drugs Market

• 20.1. Spain Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Weight Loss Drugs Market

• 21.1. Eastern Europe Weight Loss Drugs Market Overview
• 21.2. Eastern Europe Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Weight Loss Drugs Market

• 22.1. Russia Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Weight Loss Drugs Market

• 23.1. North America Weight Loss Drugs Market Overview
• 23.2. North America Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Weight Loss Drugs Market

• 24.1. USA Weight Loss Drugs Market Overview
• 24.2. USA Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Weight Loss Drugs Market

• 25.1. Canada Weight Loss Drugs Market Overview
• 25.2. Canada Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Weight Loss Drugs Market

• 26.1. South America Weight Loss Drugs Market Overview
• 26.2. South America Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Weight Loss Drugs Market

• 27.1. Brazil Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Weight Loss Drugs Market

• 28.1. Middle East Weight Loss Drugs Market Overview
• 28.2. Middle East Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Weight Loss Drugs Market

• 29.1. Africa Weight Loss Drugs Market Overview
• 29.2. Africa Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Weight Loss Drugs Market Competitive Landscape And Company Profiles

• 30.1. Weight Loss Drugs Market Competitive Landscape
• 30.2. Weight Loss Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Roche
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck & Co.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. AbbVie Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Novartis AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Weight Loss Drugs Market Other Major And Innovative Companies

• 31.1. Bristol Myers Squibb
• 31.2. Sanofi S.A.
• 31.3. AstraZeneca plc
• 31.4. LG Chem
• 31.5. GlaxoSmithKline
• 31.6. Takeda Pharmaceutical Company
• 31.7. Eli Lilly and Company
• 31.8. Bayer AG
• 31.9. Amgen Inc.
• 31.10. Boehringer Ingelheim group
• 31.11. Novo Nordisk A/S
• 31.12. Merck KGaA
• 31.13. Teva Pharmaceutical Industries Ltd.
• 31.14. Hisun Pharmaceutical
• 31.15. Taj Pharmaceuticals Ltd

32. Global Weight Loss Drugs Market Competitive Benchmarking

33. Global Weight Loss Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Weight Loss Drugs Market

35. Weight Loss Drugs Market Future Outlook and Potential Analysis

• 35.1 Weight Loss Drugs Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Weight Loss Drugs Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Weight Loss Drugs Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer